Hong Kong-listed pharma outsourcing/CRO stocks extended gains: 06821.HK rose over 6%, 03347.HK nearly 5%, 06127.HK over 3%, and 02359.HK over 2%.

2026-09-17

Hong Kong-listed pharma outsourcing/CRO stocks extended gains: 06821.HK rose over 6%, 03347.HK nearly 5%, 06127.HK over 3%, and 02359.HK over 2%.